You had to be there! Last day of #DDW kicked off with a well attended talk by @bruce_sands1, MD presenting research from the DUET-CD study which highlights the potential of dual-target therapy to improve long-term outcomes in Crohn’s disease, even in treatment-resistant patients.
Lionel D’Souza, MD walks us through how techniques like #ESD , proximal gastrectomy with functional reconstruction, and sentinel node navigation aim to preserve function, reduce morbidity, and maintain outcomes.
As monotherapy reaches its limits, the field must identify safe, effective combinations of advanced therapies in #IBD. @bruce_sands1, MD discusses key considerations for designing trials that can move research toward more meaningful, outcome-driven progress.
@DDWMeeting Day 2! Laurie Keefer, PhD’s presentation invited us to consider how chronic pain impacts our patients’ quality life in ways most may not realize. She emphasizes the value of putting function in the center of conversations with patients about their pain management.
@RobertHirten MD, shares compelling insights from his research on using wearable technology to monitor how patients with #IBD respond to biologic therapies. #DDW2026
Braved the crazy crowds and begged to get into the room to see my superstar #WorkWife@pedsIBDdoc give a wonderful talk on the use of risankizumab in pediatric patients. Rapid clinic improvement by week 12! #DDW2026@MountSinaiGI
DAY 1 of #DDW2026! Marla Dubinsky, MD presents on the importance of early, effective combination therapy at diagnosis of IBD for achieving optimal health outcomes. Special shoutout to @ryanungaro, MD’s research on proteomics to support her talk. Stay tuned for more!
Our latest Gastroenterology & GI Surgery Specialty Report highlights FDA-approved IL-23 inhibitors for Crohn’s disease, research on GLP-1 agonists & wearable tech in IBD, GI cancer risk insights, surgical innovation, and more.
Read report: https://t.co/No92ZQaH0Y
@DOMSinaiNYC
Bruce Sands, MD, discusses the potential benefits of an emerging therapeutic option for ulcerative colitis and reviews key findings from the ABTECT 1 and ABTECT 2 studies presented at the American College of Gastroenterology 2025.
https://t.co/GcbH1ldeGy
The Celiac Holiday Playbook: Join us for our next Celiac Webinar on November 17 at 7 PM, where we’ll share practical tips and strategies for navigating the holidays with celiac disease — from festive meals to social gatherings.
Register here: https://t.co/Ae72Ajoazc
Congratulations to Jean-Frédéric Colombel, MD, selected to deliver the 31st Anatomy Lesson in Amsterdam, where he will present on advancing early detection and prevention in IBD. Learn more: https://t.co/wmRUgsWKo9
We’re excited to announce the launch of https://t.co/7eIYDX9TjQ — the official website for the Women with Inflammatory Bowel Disease & Motherhood (WIsDoM) Study. @MountSinaiGI@zsgottlieb
We’re proud to celebrate an incredible showing from the Mount Sinai Division of Gastroenterology at #ACG2025! Congrats to Drs. Lucas, Advani, Sands, Greenwald, and Alexis Sherman, RN, on major honors and awards.
Full schedule: https://t.co/BK9Ca5x2VA
@DOMSinaiNYC
Marla Dubinsky, MD, and Bruce Sands, MD, MS, share findings showing an oral induction therapy led to meaningful clinical improvements in patients with moderately to severely active ulcerative colitis. @DOMSinaiNYC@Medscape
https://t.co/Itc0rl25as
The iconic @katiecouric brings in the cameras again for the ultimate CRC screening PSA 25 years later 💙
Thank you @LeadFromBehind (powered by @CCAlliance) for spreading the important message to get screened. Visit https://t.co/V3NFY9B2vq for more information.
#LeadFromBehind
Resilience and coping are critical in IBD care. @RyanUngaro, MD, & Laurie Keefer, PhD discuss their research on brain-gut behavior therapy (BGBT) alongside medical treatment to improve outcomes for patients with #Crohndisease.
https://t.co/G8546tnGXA